|
|
A40/26/0352
|
DOXORUBICIN "EBEWE" 10 mg
|
None
|
-
|
Canceled
|
Details →
|
|
|
A40/26/0353
|
DOXORUBICIN "EBEWE" 50 mg
|
None
|
-
|
Canceled
|
Details →
|
|
|
48/26/0937
|
DOXORUBICIN 10 mg/5 ml FRESENIUS
|
None
|
-
|
Registered
|
Details →
|
|
|
48/26/0938
|
DOXORUBICIN 50 mg/25 ml FRESENIUS
|
None
|
-
|
Registered
|
Details →
|
|
|
46/26/0484
|
DOXORUBICIN ACCORD 10 mg/5 ml
|
Doxorubicin hydrochloride
|
-
|
Registered
|
Details →
|
|
|
46/26/0485
|
DOXORUBICIN ACCORD 50 mg/25 ml
|
Doxorubicin hydrochloride
|
-
|
Registered
|
Details →
|
|
|
29/26/0672
|
DOXORUBICIN HCL-FAULDING 10 mg
|
None
|
-
|
Canceled
|
Details →
|
|
|
29/26/0673
|
DOXORUBICIN HCL-FAULDING 50 mg
|
None
|
-
|
Canceled
|
Details →
|
|
|
37/26/0028
|
DOXORUBICIN HEXAL 10 mg/5 ml
|
None
|
-
|
Canceled
|
Details →
|
|
|
37/26/0029
|
DOXORUBICIN HEXAL 50 mg/25 ml
|
None
|
-
|
Canceled
|
Details →
|
|
|
58/26/0248
|
DOXORUBICIN LIPOSOMAL 20mg/10 ml ACCORD
|
Doxorubicin Hydrochloride in a Pegylated Liposomal Formulation
|
-
|
Registered
|
Details →
|
|
|
58/26/0249
|
DOXORUBICIN LIPOSOMAL 50 mg/25 ml ACCORD
|
Doxorubicin Hydrochloride in a Pegylated Liposomal Formulation
|
-
|
Registered
|
Details →
|
|
|
Z/26/167
|
DOXORUBICIN-SOL PCH 10 mg
|
None
|
-
|
Registered
|
Details →
|
|
|
Z/26/170
|
DOXORUBICIN-SOL PCH 200 mg
|
None
|
-
|
Registered
|
Details →
|
|
|
Z/26/169
|
DOXORUBICIN-SOL PCH 50 mg
|
None
|
-
|
Registered
|
Details →
|
|
|
41/26/0034
|
CIPLA-DOXORUBICIN 10
|
None
|
-
|
Registered
|
Details →
|
|
|
41/26/0035
|
CIPLA-DOXORUBICIN 50
|
None
|
-
|
Registered
|
Details →
|
|
|
37/26/0030
|
HX-DOXORUBICIN 10 mg/ 5 ml
|
None
|
-
|
Registered
|
Details →
|
|
|
37/26/0031
|
HX-DOXORUBICIN 50 mg/ 25 ML
|
None
|
-
|
Registered
|
Details →
|
|
|
32/26/0507
|
BIO-DOXORUBICIN HYDROCHLORIDE 10
|
None
|
-
|
Registered
|
Details →
|